Brandeis R

References (23)

Title : Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes - Lazar_2016_Toxicol.Appl.Pharmacol_310_87
Author(s) : Lazar S , Egoz I , Brandeis R , Chapman S , Bloch-Shilderman E , Grauer E
Ref : Toxicol Appl Pharmacol , 310 :87 , 2016
PubMedID: 27639427

Title : Is rivastigmine safe as pretreatment against nerve agents poisoning? A pharmacological, physiological and cognitive assessment in healthy young adult volunteers - Lavon_2015_Neurotoxicol_49_36
Author(s) : Lavon O , Eisenkraft A , Blanca M , Raveh L , Ramaty E , Krivoy A , Atsmon J , Grauer E , Brandeis R
Ref : Neurotoxicology , 49 :36 , 2015
PubMedID: 26001567

Title : Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats - Gore_2014_Br.J.Pharmacol_171_2364
Author(s) : Gore A , Bloch-Shilderman E , Egoz I , Turetz J , Brandeis R
Ref : British Journal of Pharmacology , 171 :2364 , 2014
PubMedID: 24428128

Title : Prolonged impairment of corneal innervation after exposure to sulfur mustard and its relation to the development of delayed limbal stem cell deficiency - Kadar_2013_Cornea_32_e44
Author(s) : Kadar T , Dachir S , Cohen M , Gutman H , Cohen L , Brandeis R , Horwitz V , Amir A
Ref : Cornea , 32 :e44 , 2013
PubMedID: 23132440

Title : Magnesium sulfate treatment against sarin poisoning: dissociation between overt convulsions and recorded cortical seizure activity - Katalan_2013_Arch.Toxicol_87_347
Author(s) : Katalan S , Lazar S , Brandeis R , Rabinovitz I , Egoz I , Grauer E , Bloch-Shilderman E , Raveh L
Ref : Archives of Toxicology , 87 :347 , 2013
PubMedID: 23052190

Title : Efficacy assessment of various anticholinergic agents against topical sarin-induced miosis and visual impairment in rats - Gore_2012_Toxicol.Sci_126_515
Author(s) : Gore A , Brandeis R , Egoz I , Peri D , Turetz J , Bloch-Shilderman E
Ref : Toxicol Sci , 126 :515 , 2012
PubMedID: 22247005

Title : Efficacy of antidotal treatment against sarin poisoning: the superiority of benactyzine and caramiphen - Raveh_2008_Toxicol.Appl.Pharmacol_227_155
Author(s) : Raveh L , Rabinovitz I , Gilat E , Egoz I , Kapon J , Stavitsky Z , Weissman BA , Brandeis R
Ref : Toxicol Appl Pharmacol , 227 :155 , 2008
PubMedID: 18320638

Title : Beta-amyloids, tau hyperphosphorylation and cognition are beneficially affected by M1 muscarinic agonists. -
Author(s) : Pittel Z , Haring R , Bons N , Bar-Ner N , Sonego H , Natan N , Marcovitch I , Brandeis R
Ref : Cholinergic Mechanisms, CRC Press :345 , 2004
PubMedID:

Title : Poster (46) Major hallmarks in alzheimer's disease (ad) can beneficially be modulated by M1 muscarinic agonists - an added value vs. cholinesterase inhibitors -
Author(s) : Fisher A , Brandeis R , Pittel Z , Haring R , Sparks L , Beach TG , Bons N , Maestre-Frances N , Bar-Ner N , Kliger-Spatz M , Natan N , Marcovitch I , Hartmann T
Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :345 , 2004
PubMedID:

Title : Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction - Raveh_2003_Toxicol.Sci_75_108
Author(s) : Raveh L , Brandeis R , Gilat E , Cohen G , Alkalay D , Rabinovitz I , Sonego H , Weissman BA
Ref : Toxicol Sci , 75 :108 , 2003
PubMedID: 12832655

Title : M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy - Fisher_2003_J.Mol.Neurosci_20_349
Author(s) : Fisher A , Pittel Z , Haring R , Bar-Ner N , Kliger-Spatz M , Natan N , Egozi I , Sonego H , Marcovitch I , Brandeis R
Ref : Journal of Molecular Neuroscience , 20 :349 , 2003
PubMedID: 14501019

Title : Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig - Gilat_2003_Arch.Toxicol_77_167
Author(s) : Gilat E , Goldman M , Lahat E , Levy A , Rabinovitz I , Cohen G , Brandeis R , Amitai G , Alkalai D , Eshel G
Ref : Archives of Toxicology , 77 :167 , 2003
PubMedID: 12632257

Title : Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction - Raveh_2002_Neurotoxicol_23_7
Author(s) : Raveh L , Weissman BA , Cohen G , Alkalay D , Rabinovitz I , Sonego H , Brandeis R
Ref : Neurotoxicology , 23 :7 , 2002
PubMedID: 12164550

Title : M1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease. Rationale and perspectives - Fisher_2000_Ann.N.Y.Acad.Sci_920_315
Author(s) : Fisher A , Michaelson DM , Brandeis R , Haring R , Chapman S , Pittel Z
Ref : Annals of the New York Academy of Sciences , 920 :315 , 2000
PubMedID: 11193170

Title : M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice - Fisher_1998_J.Neurochem_70_1991
Author(s) : Fisher A , Brandeis R , Chapman S , Pittel Z , Michaelson DM
Ref : Journal of Neurochemistry , 70 :1991 , 1998
PubMedID: 9572284

Title : Quaternary-Lipophilic Carbamates with Blood Brain Barrier Permeability as Potential Drugs for the Treatment of Diseases Associated with Cholinergic Deficiency -
Author(s) : Amitai G , Adani R , Rabinovitz I , Sod-Moriah G , Brandeis R , Rachaman E , Heldman E
Ref : In: Structure and Function of Cholinesterases and Related Proteins - Proceedings of Sixth International Meeting on Cholinesterases , (Doctor, B.P., Taylor, P., Quinn, D.M., Rotundo, R.L., Gentry, M.K. Eds) Plenum Publishing Corp. :277 , 1998
PubMedID:

Title : Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis - Fisher_1998_J.Physiol.Paris_92_337
Author(s) : Fisher A , Brandeis R , Haring R , Eshhar N , Heldman E , Karton Y , Eisenberg O , Meshulam H , Marciano D , Bar-Ner N , Pittel Z
Ref : Journal de Physiologie (Paris) , 92 :337 , 1998
PubMedID: 9789833

Title : M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update - Fisher_1996_Ann.N.Y.Acad.Sci_777_189
Author(s) : Fisher A , Heldman E , Gurwitz D , Haring R , Karton Y , Meshulam H , Pittel Z , Marciano D , Brandeis R , Sadot E , Barg Y , Pinkas-Kramarski R , Vogel Z , Ginzburg I , Treves TA , Verchovsky R , Klimowsky S , Korczyn AD
Ref : Annals of the New York Academy of Sciences , 777 :189 , 1996
PubMedID: 8624083

Title : Prevention of Brain Damage and Behavioral Performance Changes following an IV Injection of Soman and VX in Rats Pretreated with Human Butyrylcholinesterase -
Author(s) : Kadar T , Raveh L , Brandeis R , Grunwald J , Cohen E , Ashani Y
Ref : In Enzyme of the Cholinesterase Family - Proceedings of Fifth International Meeting on Cholinesterases , (Quinn, D.M., Balasubramanian, A.S., Doctor, B.P., Taylor, P., Eds) Plenum Publishing Corp. :404 , 1995
PubMedID:

Title : Selective signaling via unique M1 muscarinic agonists - Fisher_1993_Ann.N.Y.Acad.Sci_695_300
Author(s) : Fisher A , Heldman E , Gurwitz D , Haring R , Barak D , Meshulam H , Marciano D , Brandeis R , Pittel Z , Segal M , et al.
Ref : Annals of the New York Academy of Sciences , 695 :300 , 1993
PubMedID: 8239299

Title : Progress in medicinal chemistry of novel selective muscarinic agonists - Fisher_1993_Drug.Des.Discov_9_221
Author(s) : Fisher A , Karton Y , Heldman E , Gurwitz D , Haring R , Meshulam H , Brandeis R , Pittel Z , Segall Y , Marciano D , et al.
Ref : Drug Des Discov , 9 :221 , 1993
PubMedID: 8400004

Title : Prevention of soman-induced cognitive deficits by pretreatment with human butyrylcholinesterase in rats - Brandeis_1993_Pharmacol.Biochem.Behav_46_889
Author(s) : Brandeis R , Raveh L , Grunwald J , Cohen E , Ashani Y
Ref : Pharmacol Biochem Behav , 46 :889 , 1993
PubMedID: 8309970

Title : (+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease - Fisher_1991_J.Pharmacol.Exp.Ther_257_392
Author(s) : Fisher A , Brandeis R , Karton I , Pittel Z , Gurwitz D , Haring R , Sapir M , Levy A , Heldman E
Ref : Journal of Pharmacology & Experimental Therapeutics , 257 :392 , 1991
PubMedID: 2019998